Menu
Back to Journals » Transplant Research and Risk Management » Volume 3
Transplant Research and Risk Management
ISSN: 1179-1616
- View all (90)
- Volume 16, 2024 (1)
- Volume 15, 2023 (1)
- Volume 14, 2022 (6)
- Volume 13, 2021 (3)
- Volume 12, 2020 (5)
- Volume 11, 2019 (8)
- Volume 10, 2018 (1)
- Volume 9, 2017 (7)
- Volume 8, 2016 (5)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5 , 2013 (3)
- Volume 4, 2012 (5)
- Volume 3, 2011 (10)
- Volume 2, 2010 (13)
- Volume 1, 2009 (2)
Archive: Volume 3, 2011
Facial transplantation: a review of ethics, progress, and future targets
Edwards JA, Mathes DW
Transplant Research and Risk Management 2011, 3:113-125
Published Date: 5 September 2011
Everolimus in kidney transplantation
Cooper JE, Christians U, Wiseman AC
Transplant Research and Risk Management 2011, 3:97-112
Published Date: 8 July 2011
Evaluation of medication errors via a computerized physician order entry system in an inpatient renal transplant unit
Marfo K, Garcia D, Khalique S, Berger K, Lu A
Transplant Research and Risk Management 2011, 3:91-96
Published Date: 18 May 2011
Long-term outcome of everolimus treatment in transplant patients
Salvadori M, Bertoni E
Transplant Research and Risk Management 2011, 3:77-90
Published Date: 13 May 2011
Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients
Martin ST, Tsapepas D, Gabardi S, Chandraker A
Transplant Research and Risk Management 2011, 3:65-75
Published Date: 12 April 2011
Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials
Jackson RM, Gomez-Marin O
Transplant Research and Risk Management 2011, 3:55-63
Published Date: 11 April 2011
Mycophenolic acid agents: is enteric coating the answer?
Manitpisitkul W, Lee S, Cooper M
Transplant Research and Risk Management 2011, 3:45-53
Published Date: 29 March 2011
Pathophysiology, prevention, and treatment of acute graft-versus-host disease
Abhinav Deol, Voravit Ratanatharathorn, Joseph P Uberti
Transplant Research and Risk Management 2011, 3:31-44
Published Date: 7 March 2011
Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation
Helio Tedesco-Silva Jr, Claudia Rosso Felipe, Tainá Veras de Sandes Freitas, et al
Transplant Research and Risk Management 2011, 3:9-29
Published Date: 24 January 2011
Human amniotic membrane, best healing accelerator, and the choice of bone induction for vestibuloplasty technique (an animal study)
Mohammad H Samandari, Shahriar Adibi, Ahad Khoshzaban, et al
Transplant Research and Risk Management 2011, 3:1-8
Published Date: 22 December 2010